These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19913014)

  • 1. Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice.
    Beahrs T; Tanzer L; Sanders VM; Jones KJ
    Exp Neurol; 2010 Jan; 221(1):225-30. PubMed ID: 19913014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice.
    Serpe CJ; Byram SC; Sanders VM; Jones KJ
    Brain Behav Immun; 2005 Mar; 19(2):173-80. PubMed ID: 15664790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice.
    Serpe CJ; Sanders VM; Jones KJ
    J Neurosci Res; 2000 Oct; 62(2):273-8. PubMed ID: 11020219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.
    Deboy CA; Xin J; Byram SC; Serpe CJ; Sanders VM; Jones KJ
    Exp Neurol; 2006 Sep; 201(1):212-24. PubMed ID: 16806176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection.
    Serpe CJ; Coers S; Sanders VM; Jones KJ
    Brain Behav Immun; 2003 Oct; 17(5):393-402. PubMed ID: 12946661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells do not mediate facial motoneuron survival after facial nerve transection.
    Byram SC; Serpe CJ; Pruett SB; Sanders VM; Jones KJ
    Brain Behav Immun; 2003 Dec; 17(6):417-25. PubMed ID: 14583233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a resilient mouse facial motoneuron population following target disconnection by injury or disease.
    Setter DO; Haulcomb MM; Beahrs T; Meadows RM; Schartz ND; Custer SK; Sanders VM; Jones KJ
    Restor Neurol Neurosci; 2018; 36(3):417-422. PubMed ID: 29614705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of peripheral immune status on central molecular responses to facial nerve axotomy.
    Setter DO; Runge EM; Schartz ND; Kennedy FM; Brown BL; McMillan KP; Miller WM; Shah KM; Haulcomb MM; Sanders VM; Jones KJ
    Brain Behav Immun; 2018 Feb; 68():98-110. PubMed ID: 29030217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4(+) T cell-mediated facial motoneuron survival after injury: Distribution pattern of cell death and rescue throughout the extent of the facial motor nucleus.
    Canh MY; Serpe CJ; Sanders V; Jones KJ
    J Neuroimmunol; 2006 Dec; 181(1-2):93-9. PubMed ID: 17045343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous T lymphocytes and microglial reactivity in the axotomized facial motor nucleus of mice: effect of genetic background and the RAG2 gene.
    Ha GK; Huang Z; Streit WJ; Petitto JM
    J Neuroimmunol; 2006 Mar; 172(1-2):1-8. PubMed ID: 16376435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
    Xin J; Wainwright DA; Serpe CJ; Sanders VM; Jones KJ
    Brain Behav Immun; 2008 May; 22(4):528-37. PubMed ID: 18024079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodeficiency impairs re-injury induced reversal of neuronal atrophy: relation to T cell subsets and microglia.
    Ha GK; Huang Z; Parikh R; Pastrana M; Petitto JM
    Exp Neurol; 2007 Nov; 208(1):92-9. PubMed ID: 17761165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T cell expression of the IL-10 receptor is necessary for facial motoneuron survival after axotomy.
    Runge EM; Iyer AK; Setter DO; Kennedy FM; Sanders VM; Jones KJ
    J Neuroinflammation; 2020 Apr; 17(1):121. PubMed ID: 32303238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune cell-mediated neuroprotection is independent of estrogen action through estrogen receptor-alpha.
    Xin J; Fargo KN; Tanzer L; Sanders VM; Jones KJ
    Metab Brain Dis; 2012 Mar; 27(1):23-8. PubMed ID: 21975535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell memory in the injured facial motor nucleus: relation to functional recovery following facial nerve crush.
    Ha GK; Pastrana M; Huang Z; Petitto JM
    Neurosci Lett; 2008 Oct; 443(3):150-4. PubMed ID: 18687384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice.
    Serpe CJ; Kohm AP; Huppenbauer CB; Sanders VM; Jones KJ
    J Neurosci; 1999 Jun; 19(11):RC7. PubMed ID: 10341268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 and IL-15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy.
    Huang Z; Ha GK; Petitto JM
    Neurosci Lett; 2007 May; 417(2):160-4. PubMed ID: 17418948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.
    Mesnard-Hoaglin NA; Xin J; Haulcomb MM; Batka RJ; Sanders VM; Jones KJ
    Brain Behav Immun; 2014 Aug; 40():55-60. PubMed ID: 24911596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of axotomy-induced pituitary adenylyl cyclase-activating peptide gene expression in T helper 2 lymphocyte-deficient mice.
    Armstrong BD; Abad C; Chhith S; Cheung-Lau G; Hajji OE; Coute AC; Ngo DH; Waschek JA
    Neuroreport; 2006 Feb; 17(3):309-12. PubMed ID: 16462603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+CD25+ regulatory T cells and CD1-restricted NKT cells do not mediate facial motoneuron survival after axotomy.
    DeBoy CA; Byram SC; Serpe CJ; Wisuri D; Sanders VM; Jones KJ
    J Neuroimmunol; 2006 Jul; 176(1-2):34-8. PubMed ID: 16766044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.